Role and evolution of therapeutic options.
Keen
R W
RW
Rheumatology Department, St Thomas' Hospital, London, UK.
Spector
T D
TD
D045930:Anabolic Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005459:Fluorides / Q000627:therapeutic use; D006801:Humans; D010024:Osteoporosis / Q000628:therapy*; D010281:Parathyroid Hormone / Q000627:therapeutic use; D012219:Rheumatology / Q000639:trends*; D014807:Vitamin D / Q000627:therapeutic use
D045930:Anabolic Agents; D004164:Diphosphonates; D010281:Parathyroid Hormone; D014807:Vitamin D; D002116:Calcitonin; D005459:Fluorides; D002118:Calcium